Estimation of 10-year risk of fatal cardiovascular disease and coronary heart disease in Iceland with results comparable with those of the Systematic Coronary Risk Evaluation project

European Journal of Preventive Cardiology

Volumn 14, Issue 6, 2007, Pages 761-768

  Aspelund, Thor ^a   Thorgeirsson, Gudmundur ^a,b   Sigurdsson, Gunnar ^a,b   Gudnason, Vilmundur ^a  

^a ICELANDIC HEART ASSOCIATION   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

cardiovascualar disease; coronary heart disease; Europe; Iceland; risk estimation; risk score

Indexed keywords

ADULT; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY RISK; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; ICELAND; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORBIDITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ICELAND; MALE; MORBIDITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 36649037013     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32825fea6d     Document Type: Article

References (24)

1. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatalcardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.
2. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heartdisease in men and women from Germany: results from the MONICA Augsburg andthe PROCAM cohorts. Eur Heart J 2003; 24: 937–945.
3. Neuhauser HK, Ellert U, Kurth BM. A comparison of Framingham and SCORE-based cardiovascular riskestimates in participants of the German National Health Interview andExamination Survey 1998. Eur J Cardiovasc PrevRehabll 2005; 12: 442–450.
4. Thomsen TF, McGee D, Davidsen M, Jorgensen T. A cross-validation of risk-scores for coronary heart diseasemortality based on data from the Glostrup Population Studies and FraminghamHeart Study. Int J Epidemiol 2002; 31: 817–822.
5. Pyorala K. Assessment of coronary heart disease risk in populations withdifferent levels of risk. Eur Heart J 2000; 21: 348–350.
6. Menotti A, Lanti M, Puddu PE, Kromhout D. Coronary heart disease incidence in northern and southernEuropean populations: a reanalysis of the seven countries study for aEuropean coronary risk chart. Heart 2000; 84: 238–244.
7. Graham IM, Leong T. Whither cardiovascular riskprediction? Eur J Cardiovasc Prev Rehabil 2005; 12: 421–423.
8. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovasculardisease prevention in clinical practice. Third Joint Task Force of Europeanand Other Societies on Cardiovascular Disease Prevention in ClinicalPractice. Eur Heart J 2003; 24: 1601–1610.
9. Assmann G, Cullen P, Schulte H, Hense HW. Response to Conroy et al. SCORE project. Eur Heart J 2003; 24: 2070–2071.
10. Jonsdottir LS, Sigfusson N, Sigvaldason H, Thorgeirsson G. Incidence and prevalence of recognised and unrecognisedmyocardial infarction in women. The Reykjavik Study. Eur Heart J 1998; 19: 1011–1018.
11. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Prevalence of coronary heart disease in Icelandic men 1968-1986.The Reykjavik Study. Eur Heart J 1993; 14: 584–591.
12. Hawthorne V, Kozarevic D, Vojvodic N, Gillis C, Hole D, Hart C, et al. Prediction of mortality from coronaryheart disease among diverse populations: is there a common predictivefunction? Heart 2002; 88: 222–228.
13. Statistics-Iceland. The National Statistical Institute of Iceland, Reykjavik Iceland;2002.
14. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas A, Pajak A. Myocardial infarction and coronary deaths in the World HealthOrganization MONICA Project. Registration procedures, event rates, andcase-fatality rates in 38 populations from 21 countries in fourcontinents. Circulation 1994; 90: 583–612.
15. Pencina MJ, Larson MG, D'Agostino RB. Choice of time scale and its effect on significance of predictorsin longitudinal studies. Stat Med 2007; 26: 1343–1359.
16. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey:Choice of time scale. Am J Epidemiol 1997; 145: 72–80.
17. Thiebaut AC, Benichou J. Choice of time-scale in Cox's model analysis ofepidemiologic cohort data: a simulation study. StatMed 2004; 23: 3803–3820.
18. Cleves MA, Gould WW, Gutierrez RG. An introduction to survival analysis using STATA. Texas, USA: STATAPress; 2004.
19. D'Agostino S, Ralph B, Grundy S, Sullivan LM, Wilson P, For the CHD Risk Prediction Group Validation ofthe Framingham coronary heart disease prediction scores: results of amultiple ethnic group investigation 10.1001/jama.286.2.180. JAMA 2001; 286: 180–187.
20. Getz L, Sigurdsson JA, Hetlevik I, Kirkengen AL, Romundstad S, Holmen J. Estimating the high risk group for cardiovascular disease in theNorwegian HUNT 2 population according to the 2003 European guidelines:modelling study. BMJ 2005; 331: 551–556.
21. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates tochanges in coronary heart disease mortality: 10-year results from 37 WHOMONICA project populations. Monitoring trends and determinants incardiovascular disease. Lancet 1999; 353: 1547–1557.
22. Sarti C, Stegmayr B, Tolonen H, Mahonen M, Tuomilehto J, Asplund K. Are changes in mortality from stroke caused by changes in strokeevent rates or case fatality? Results from the WHO MONICAProject. Stroke 2003; 34: 1833–1840.
23. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice.Recommendations of the Second Joint Task Force of European and otherSocieties on coronary prevention. Eur Heart J 1998; 19: 1434–1503.
24. Wilhelmsen L, Wedel H, Conroy R, Fitzgerald T. [The Swedish SCORE chart for cardiovascular risk. Betterpossibilities for prevention of cardiovascular diseases]. Lakartidningen 2004; 101: 1798–1801.